中恒集团：控股孙公司获得医疗器械注册证

Core Insights - Zhongheng Group (600252.SH) announced that its subsidiary, Chongqing Laimei Pharmaceutical, received two medical device registration certificates from the Hainan Provincial Drug Administration for a medical electronic endoscope image processor and an electronic bronchoscope, both valid from November 17, 2025, to November 16, 2030 [1] Company Developments - The newly certified products allow direct observation of patient images, aiding in clinical diagnosis and treatment [1] - The certification will enhance the variety of medical device products offered by the company, meeting diverse market demands and improving overall competitiveness [1] - The positive impact on future operations is anticipated as a result of these developments [1]